Neural Regeneration Research ›› 2017, Vol. 12 ›› Issue (1): 125-132.doi: 10.4103/1673-5374.199004

Previous Articles     Next Articles

Propofol protects against blood-spinal cord barrier disruption induced by ischemia/reperfusion injury

Li-jie Xie1, Jin-xiu Huang1, Jian Yang1, Fen Yuan1, Shuang-shuang Zhang1, Qi-jing Yu2, Ji Hu1   

  1. 1 Department of Anesthesiology, Liyuan Hospital of Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei Province, China; 
    2 Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China
  • Received:2016-11-21 Online:2017-01-15 Published:2017-01-15
  • Contact: Ji Hu M.D., hbwhly01@163.com.
  • Supported by:

    supported by the Natural Science Foundation of Hubei Province, No. 2013CFB086; a grant from the Basic Research Funds of the Huazhong University of Science & Technology, No. 2016YXZDO24;and a grant from the Scientific Research project of the Health and Family Planning Commission of Hubei Province, No. WJ2015MB023.

Abstract:

 

Propofol has been shown to exert neuroprotective effects on the injured spinal cord. However, the effect of propofol on the blood–spinal cord barrier (BSCB) after ischemia/reperfusion injury (IRI) is poorly understood. Therefore, we investigated whether propofol could maintain the integrity of the BSCB. Spinal cord ischemia/reperfusion injury (SCIRI) was induced in rabbits by infrarenal aortic occlusion for 30 minutes.Propofol, 30 mg/kg, was intravenously infused 10 minutes before aortic clamping as well as at the onset of reperfusion. Then, 48 hours later, we performed histological and mRNA/protein analyses of the spinal cord. Propofol decreased histological damage to the spinal cord, attenuated the reduction in BSCB permeability, downregulated the mRNA and protein expression levels of matrix metalloprotease-9 (MMP-9) and nuclear factor-κB (NF-κB), and upregulated the protein expression levels of occludin and claudin-5. Our findings suggest that propofol helps maintain BSCB integrity after SCIRI by reducing MMP-9 expression, by inhibiting the NF-κB signaling pathway, and by maintaining expression of tight junction proteins.

Key words: nerve regeneration, spinal cord ischemia reperfusion injury, blood–spinal cord barrier, propofol, matrix metalloprotease-9, nuclear factor-κB, tight junction proteins, neural regeneration